Guaifenesin and Diamox drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Guaifenesin and Diamox. Common interactions include respiratory distress among females and migraine among males.

The phase IV clinical study analyzes what interactions people who take Guaifenesin and Diamox have. It is created by eHealthMe based on reports of 7 people who take Guaifenesin and Diamox from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Nov, 30, 2022

7 people who take Guaifenesin and Diamox together, and have interactions are studied.


What is Guaifenesin?

Guaifenesin has active ingredients of guaifenesin. It is often used in cough. eHealthMe is studying from 10,667 Guaifenesin users for its effectiveness, alternative drugs and more.

What is Diamox?

Diamox has active ingredients of acetazolamide. It is often used in pseudotumor cerebri. eHealthMe is studying from 4,316 Diamox users for its effectiveness, alternative drugs and more.

Number of Guaifenesin and Diamox reports submitted per year:

Guaifenesin and Diamox drug interactions.

Common Guaifenesin and Diamox drug interactions by gender *:

female:

  1. Respiratory distress
  2. Respiratory failure
  3. Sepsis
  4. Deep vein thrombosis
  5. Pulmonary embolism
  6. Abdominal distension
  7. Abdominal pain
  8. Abdominal pain upper
  9. Alopecia
  10. Arthralgia

male:

  1. Migraine
  2. Pre-existing condition improved
  3. Therapeutic response unexpected

Common Guaifenesin and Diamox drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Deep vein thrombosis
  2. Pulmonary embolism
  3. Cholelithiasis
  4. Gait disturbance
  5. Pain
  6. Peroneal nerve palsy

40-49:

n/a

50-59:

n/a

60+:

  1. Cardiac arrest
  2. General physical health deterioration
  3. Abdominal distension
  4. Abdominal pain
  5. Abdominal pain upper
  6. Alopecia
  7. Arthralgia
  8. Back pain
  9. Chest discomfort
  10. Choking

* Approximation only. Some reports may have incomplete information.

Do you take Guaifenesin and Diamox?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related publications that referenced our studies

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Guaifenesin and Diamox:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Guaifenesin side effects:

Browse all side effects of Guaifenesin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Diamox side effects:

Browse all side effects of Diamox:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Guaifenesin interactions:

Browse all interactions between Guaifenesin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Diamox interactions:

Browse all interactions between Diamox and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on guaifenesin and acetazolamide (the active ingredients of Guaifenesin and Diamox, respectively), and Guaifenesin and Diamox (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Guaifenesin and Diamox.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: